The history of research funding for ME in the UK has long been a point of contention for patient advocacy groups. Between April 2019 and March 2024, the UK government invested approximately £6.5 million into research specifically targeting the condition. While this represents a baseline of support, critics argue it is a fraction of what is allocated to other chronic conditions with similar levels of disability and prevalence.
There have been signs of progress in recent months. Earlier this year, under the leadership of then-Prime Minister Sir Keir Starmer, the government announced a £4.75 million investment into a world-first genomics study. This study aims to identify genetic markers associated with the condition, potentially paving the way for the development of targeted diagnostic tests and treatments. However, for patients like Dobbin, who are currently living in the "life-decimating" shadow of the disease, these steps—while welcomed—are seen as only the beginning of a much larger required effort.
The current medical landscape for ME sufferers is often one of trial and error. Without approved, evidence-based treatments, many patients are forced to rely on "off-label" medications—drugs approved for other conditions—to manage their symptoms. This lack of a standardized treatment protocol further complicates the lives of patients and their caregivers, who must often act as their own medical researchers.
Dobbin’s transition from an elite athlete to a bedbound advocate has provided a powerful face to a condition that is often hidden behind closed doors. Her story has resonated with the ME community, many of whom have expressed solidarity with her call for Prime Minister Burnham to take decisive action. The narrative of an Olympian—someone who possessed extraordinary physical resilience—being brought to a standstill by ME serves as a potent reminder that the disease can affect anyone, regardless of their prior health or fitness levels.
As the government considers its fiscal priorities and the future of the NHS, the voices of the hundreds of thousands of ME sufferers remain a critical part of the conversation. Dobbin’s letter serves as both a plea for help and a strategic roadmap for a government looking to address the rising costs of long-term illness.
Number 10 has been contacted for comment regarding the points raised in Dobbin’s letter and the future of research funding for the condition. For now, Dobbin remains in her bed, waiting for a response that could signal a turning point for a community that has spent decades in the dark. The hope is that the Prime Minister’s commitment to economic reform will include the scientific and medical breakthroughs necessary to return thousands of individuals to health and independence.
